In a report released today, A.J. Rice from Credit Suisse maintained a Hold rating on Mednax Inc (NYSE: MD), with a price target of $47. The company’s shares closed on Friday at $45.22.
According to TipRanks.com, Rice is a 4-star analyst with an average return of 9.1% and a 61.2% success rate. Rice covers the Services sector, focusing on stocks such as Encompass Health Corporation, AMN Healthcare Services Inc, and Quest Diagnostics Inc.
Currently, the analyst consensus on Mednax Inc is Moderate Buy and the average price target is $56.43, representing a 24.8% upside.
In a report issued on May 2, SunTrust Robinson also maintained a Hold rating on the stock with a $50 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $63.04 and a one-year low of $40.56. Currently, Mednax Inc has an average volume of 929.3K.
Based on the recent corporate insider activity of 44 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of MD in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company’s solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting.
